PROTEOGLYCANS IN CHONDRODYSPLASIA
PROTEOGLYCANS IN CHONDRODYSPLASIA
批准号:
3152315
负责人:
Thomas N Wight
金额:
$10.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-01-01 至 1985-12-31
关键词:
achondroplasia autoradiography autosomal recessive trait density gradient ultracentrifugation disease /disorder model dwarfism gel electrophoresis high performance liquid chromatography immunochemistry immunoelectron microscopy molecular pathology molecular sieving monomer mucopolysaccharides proteoglycan scintillation counter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The skeletal dysplasias consist of a heterogeneous group of inherited
defects which are characterized by significantly altered endochondral
ossification in the long bones of skull, and vertabrate of various affected
species including man. With the exception of the mucopolysacharidoses, the
molecular basis for the altered endochondral ossification in these affected
individuals is largely unknown. One animal model which has proven useful
in the study of chondrodysplasia is the Alaskan Malamute, since
chondrodysplasia in these animals bears clinical and radiographic
resemblance to human metaphysical chondrodysplasias. Previous biochemical
studies in our laboratory of the growth plates in these animals have failed
to reveal any primary defect in collagen metabolism, but ultrastructural
studies of the territorial and interterritorial matrix comprising the
affected growth plates reveal an abnormal organization and distribution of
proteoglycan matrix granules. The objective of this proposal will be to
determine whether there is a defect in proteoglycan components of the dwarf
growth plates by using the techniques of biochemistry and morphology.
Specifically, we will determine whether there are qualitative and
quantitative differences in the physical-chemical nature of the
proteoglycans present in dwarf growth plate by examining the size class of
the entire proteoglycan monomers, the glycosaminoglycan constituents, and
the overall size of the protein core which constitutes the back bone of the
monomer. This will be accomplished by using conventional methods of
extracting the proteoglycans with 4M quanidine HCl in the presence of
protease inhibitors, purifying the proteoglycans by density gradient
centrifugation and sizing the molecules by molecular sieve chromatography,
high pressure liquid chromatography, SDS polyacrylamide electrophoresis and
electron microscopy. In addition, studies will be conducted to determine
whether the state of proteoglycan aggregation is altered in the dwarf
growth plate. The presence of native PG aggregate, the presence and
character of link proteins, and the ability of proteoglycan monomers from
dwarf and normal growth plates to form aggregate (either "link" free or
"link" stable) will be assessed using density gradient ultracentrifugation,
molecular sieve components of the aggregate (i.e. link protein) as well as
the monomer to immuno-electron microscopically examine the dwarf growth
plate for evidence of altered PG aggregation. Finally, we will establish
organ cultures for normal and dwarf growth plates to determine if there is
in alteration in the synthesis and/or degradation of proteoglycans in the
swarf utilizing incorporation of 35S-sulfate, 3H glucosamine, 3H serine
into proteoglycans. Autoradiography will also be done.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Undersulfated chondroitin sulfate in cartilage from a miniature poodle with spondyloepiphyseal dysplasia.
来自患有脊椎骨骺发育不良的小型贵宾犬的软骨中硫酸化不足的硫酸软骨素。
DOI:
10.3109/03008208609001986
发表时间:
1986
期刊:
Connective tissue research
影响因子:
2.9
作者:
[Bingel,SA, Sande,RD, Wight,TN]
通讯作者:
Wight,TN
Targeting the Extracellular Matrix to Inhibit Saphenous Vein Graft (SVG) Failure
-
批准号:8318591
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2011
-
负责人:Thomas N Wight
-
依托单位:
Targeting the Extracellular Matrix to Inhibit Saphenous Vein Graft (SVG) Failure
-
批准号:8200545
-
项目类别:
-
资助金额:$34.3万
-
财政年份:2011
-
负责人:Thomas N Wight
-
依托单位:
Extracellular Matrix in the Innate Response in Lung Inflammation
-
批准号:8005411
-
项目类别:
-
资助金额:$51.49万
-
财政年份:2010
-
负责人:Thomas N Wight
-
依托单位:
2008 Proteoglycans Gordon Research Conference
-
批准号:7533667
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2008
-
负责人:Thomas N Wight
-
依托单位:
Pro-Inflammatory ECM: Key Roles for Hyaluronan and Versican
-
批准号:7140040
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2005
-
负责人:Thomas N Wight
-
依托单位:
Regulation of Cell Function by Matricellular Hevin
-
批准号:7407527
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2004
-
负责人:Thomas N Wight
-
依托单位:
Regulation of Cell Function by Matricellular Hevin
-
批准号:7228904
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2004
-
负责人:Thomas N Wight
-
依托单位:
Use of Proteoglycan-Genes to Engineer Vascular Tissue
-
批准号:6661317
-
项目类别:
-
资助金额:$21.01万
-
财政年份:2002
-
负责人:Thomas N Wight
-
依托单位:
Use of Proteoglycan-Genes to Engineer Vascular Tissue
-
批准号:6571306
-
项目类别:
-
资助金额:$27.38万
-
财政年份:2002
-
负责人:Thomas N Wight
-
依托单位:
Use of Proteoglycan-Genes to Engineer Vascular Tissue
-
批准号:6787184
-
项目类别:
-
资助金额:$26.33万
-
财政年份:2002
-
负责人:Thomas N Wight
-
依托单位:
Use of Proteoglycan-Genes to Engineer Vascular Tissue
-
批准号:6844178
-
项目类别:
-
资助金额:$6.37万
-
财政年份:2002
-
负责人:Thomas N Wight
-
依托单位:
PROTEOGLYCANS, GLYCOSAMINOGLYCANS AND ATHEROSCLEROSIS
-
批准号:6654165
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2002
-
负责人:Thomas N Wight
-
依托单位:
PROTEOGLYCANS, GLYCOSAMINOGLYCANS AND ATHEROSCLEROSIS
-
批准号:6488255
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2001
-
负责人:Thomas N Wight
-
依托单位:
PROTEOGLYCANS, GLYCOSAMINOGLYCANS AND ATHEROSCLEROSIS
-
批准号:6353045
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2000
-
负责人:Thomas N Wight
-
依托单位:
PROTEOGLYCANS, GLYCOSAMINOGLYCANS IN ATHEROSCLEROSIS
-
批准号:6202172
-
项目类别:
-
资助金额:$25.32万
-
财政年份:1999
-
负责人:Thomas N Wight
-
依托单位:
PROTEOGLYCANS, GLYCOSAMINOGLYCANS IN ATHEROSCLEROSIS
-
批准号:6109452
-
项目类别:
-
资助金额:$25.32万
-
财政年份:1998
-
负责人:Thomas N Wight
-
依托单位:
PROTEOGLYCANS, GLYCOSAMINOGLYCANS IN ATHEROSCLEROSIS
-
批准号:6241580
-
项目类别:
-
资助金额:$23.85万
-
财政年份:1997
-
负责人:Thomas N Wight
-
依托单位:
MECHANISM OF MATRIX MODULATION OF IL 1 SIGNALING
-
批准号:2749344
-
项目类别:
-
资助金额:$16.88万
-
财政年份:1995
-
负责人:Thomas N Wight
-
依托单位:
MECHANISM OF MATRIX MODULATION OF IL 1 SIGNALING
-
批准号:2458637
-
项目类别:
-
资助金额:$16.23万
-
财政年份:1995
-
负责人:Thomas N Wight
-
依托单位:
Extracellular Matrix in the Innate Immune Response in Lung Inflammation
-
批准号:8701346
-
项目类别:
-
资助金额:$41.14万
-
财政年份:--
-
负责人:Thomas N Wight
-
依托单位:
海外基金